Real-world evaluation of the HistoSonics Edison System for treatment of liver tumors across multidisciplinary users (BOOMBOX: Master)
-
Enrollment
This study is currently enrolling. -
Associated Conditions
-
Research Area
Digestive Health and Surgery -
Location
-
Principal Investigator
-
Sponsor
HistoSonics Inc
The HistoSonics Edison System was cleared for use by the United States Food and Drug Administration (FDA) in 2023 for the non-invasive mechanical destruction of liver tumors. The device is not experimental when used to treat liver tumors. The purpose of this study is to collect information on the use of the HistoSonics Edison System for the treatment of liver tumors.
Enrollment Form
This study is currently enrolling.